Karyopharm Therapeutics Inc. (KPTI) quarterly cash flow statement — complete operating, investing & financing history
Karyopharm Therapeutics Inc. (KPTI) cash flow statement — 15-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -24.93M | -22.73M | -11.83M | -5.86M | -18.7M | -38.98M | -25.81M | -19.45M | -38.5M | -43.73M | -18.59M | -29.53M | -25.7M | -18.91M | -26.84M | -28.37M | -35.14M | -59.2M | 25.48M | -23.95M |
| Operating CF Margin % | -74.57% | -64.81% | -34.71% | -13.3% | -49.29% | -129.88% | -84.51% | -50.16% | -89.98% | -132% | -55.07% | -82.01% | -68.38% | -48.87% | -79.94% | -78.49% | -88.57% | -124.18% | 20.18% | -63.56% |
| Operating CF Growth % | -33.34% | 41.7% | 54.17% | 69.88% | 51.43% | 10.84% | -38.88% | 34.12% | -49.81% | -131.23% | 30.76% | -4.09% | 26.88% | 68.06% | -205.37% | -18.43% | 36.96% | -11.93% | 183.16% | 45.94% |
| Net Income | -67.02M | -22.39M | -102.2M | -33.13M | -37.25M | -23.46M | -30.78M | -32.07M | 23.79M | -37.36M | -41.84M | -34.51M | -32.63M | -34.13M | -38.51M | -36.32M | -49.06M | -41.4M | 38.72M | -51.81M |
| Depreciation & Amortization | -3K | 12K | 19K | 121K | 78K | 78K | 81K | 83K | 91K | 85K | 294K | 285K | 274K | 290K | 113K | 182K | 351K | 375K | 338K | 381K |
| Stock-Based Compensation | 1.93M | 3.01M | 3.9M | 2.8M | 3.78M | 3.56M | 3.86M | 4.18M | 5.41M | 4.97M | 5.18M | 5.08M | 6.06M | 5.39M | 6.17M | 6.8M | 15.09M | 7.34M | 6.87M | 7.42M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 38.89M | -7.21M | 80.95M | 10.1M | 4.64M | -17.64M | -9.06M | 861K | -58.32M | 1.2M | 1.16M | -2.28M | -7.78M | -921K | -532K | -87K | -1.86M | 1.88M | 1.29M | 6.04M |
| Working Capital Changes | 1.27M | 3.85M | 5.5M | 14.25M | 10.05M | -1.52M | 10.08M | 7.49M | -9.47M | -12.62M | 16.62M | 1.89M | 8.38M | 10.46M | 5.91M | 1.06M | 338K | -27.39M | -21.75M | 14.02M |
| Change in Receivables | -6.51M | 2.82M | 5.7M | 1.05M | 2.31M | -4.48M | 1.01M | 6.22M | -6.91M | -4.12M | 10.96M | -5.64M | 2.92M | 11.89M | -135K | -3.97M | 1.51M | -2.5M | -3.75M | -865K |
| Change in Inventory | -395K | 439K | -72K | 1.03M | -223K | -30K | -67K | -1.2M | -707K | 274K | 62K | 567K | 155K | 397K | 25K | -779K | 404K | 232K | -77K | 121K |
| Change in Payables | 3.38M | 276K | -1.39M | 2.79M | -3.27M | 765K | 0 | 0 | -2.23M | 0 | 0 | 0 | 0 | 6.27M | 1.96M | -881K | 0 | 0 | 0 | 0 |
| Cash from Investing | -10.04M | 3.2M | 5M | 4.8M | 18.29M | 15.29M | 14.8M | 7.47M | 51.26M | 21.94M | 26.84M | -7.68M | 21.17M | -32.39M | -65.3M | 11.67M | -36.6M | -14.04M | 30.77M | 21.43M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 53K | 0 | 0 | -195K | 0 | 0 | 0 | 0 | 79K | -39K | 0 | -79K | -207K | -5K |
| CapEx % of Revenue | - | - | - | - | - | - | 0.17% | - | - | 0.59% | - | - | - | - | 0.24% | 0.11% | - | 0.17% | 0.16% | 0.01% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.71M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 14.74M | 7.47M | 0 | 22.14M | 26.84M | -7.68M | 21.17M | 0 | -79K | 11.71M | -36.6M | -13.96M | 30.98M | 21.43M |
| Cash from Financing | -898K | 49.8M | 29.69M | 0 | 356K | 0 | 680K | 0 | 40.97M | 0 | 264K | 0 | 860K | 0 | 155.84M | 5.8M | 1.31M | 30.78M | 896K | 16K |
| Debt Issued (Net) | 0 | 0 | 20.54M | 0 | 0 | 0 | 0 | 0 | 40.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 574K | 50.23M | 9.15M | 0 | 356K | 0 | 0 | 0 | 772K | 0 | 0 | 0 | 0 | 0 | 154.68M | 5.79M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.47M | -431K | 0 | 0 | 0 | 0 | 680K | 0 | 0 | 0 | 264K | 0 | 860K | 0 | 1.16M | 11K | 1.31M | 30.78M | 896K | 16K |
| Net Change in Cash | -35.87M | 30.31M | 22.87M | -1.05M | -48K | -23.69M | -10.35M | -11.94M | 53.72M | -21.8M | 8.61M | -37.27M | -3.69M | -51.34M | 63.83M | -10.97M | -70.88M | -42.54M | 57.01M | -2.27M |
| Free Cash Flow | -24.93M | -22.73M | -11.83M | -5.86M | -18.7M | -38.98M | -25.76M | -19.45M | -38.5M | -43.92M | -18.59M | -29.53M | -25.7M | -18.91M | -26.76M | -28.41M | -35.14M | -59.28M | 25.27M | -23.96M |
| FCF Margin % | -74.57% | -64.81% | -34.71% | -13.3% | -49.29% | -129.88% | -84.33% | -50.16% | -89.98% | -132.58% | -55.07% | -82.01% | -68.38% | -48.87% | -79.7% | -78.6% | -88.57% | -124.35% | 20.01% | -63.57% |
| FCF Growth % | -33.34% | 41.7% | 54.08% | 69.88% | 51.43% | 11.24% | -38.59% | 34.12% | -49.81% | -132.26% | 30.56% | -3.95% | 26.88% | 68.1% | -205.92% | -18.57% | 36.96% | -12.08% | 182.16% | 45.93% |
| FCF per Share | -0.86 | -0.92 | -0.65 | -0.68 | -2.17 | -4.60 | -3.07 | -2.33 | -3.74 | -5.71 | -2.43 | -3.87 | -0.23 | -2.50 | -0.30 | -0.35 | -0.44 | -0.76 | 0.29 | -0.32 |
| FCF Conversion (FCF/Net Income) | 0.37x | 1.02x | 0.12x | 0.18x | 0.50x | 1.66x | 0.84x | 0.61x | -1.62x | 1.17x | 0.44x | 0.86x | 0.79x | 0.55x | 0.70x | 0.78x | 0.72x | 1.43x | 0.66x | 0.46x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 8.2M | 11.01M | 0 | 4.1M | 6.42M | 4.03M | 6.7M | 4.08M | 0 | 0 | 7.55M | 15.78M | 7.3M | 1.58M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |